tm
Seeing Is Believing
tm
Seeing Is Believing
PPBT is currently covered by 1 analysts
Purple Biotech's activity chart (see below) currently has 15 price targets and 19 ratings on display. The stock rating distribution of PPBT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 64.17% with an average time for these price targets to be met of 212.4 days.
Highest price target for PPBT is $1, Lowest price target is $1.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 07-Aug-2026. First documented stock forecast 21-Nov-2017.
Currently out of the existing stock ratings of PPBT, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Oct-2022
1 months 25 days ago
(07-Aug-2026)
3/8 (37.5%)
$314 (1207.69%)
226
Buy Since 21-Jul-2023
$300
$298.49 (19767.55%)
$160
2 years 3 months 29 days ago
(03-Jun-2024)
1/2 (50%)
$152 (102.70%)
144
Buy Since 08-Sep-2022
$220
$218.49 (14469.54%)
$220
3 years 4 months 15 days ago
(17-May-2023)
2/3 (66.67%)
$-157 (-41.64%)
124
Buy Since 21-Nov-2017
$60
$56.02 (1407.54%)
$60
6 years 4 days ago
(28-Sep-2020)
5/5 (100%)
$-25.2 (-29.58%)
320
What is PPBT (Purple Biotech) average time for price targets to be met?
Which analyst most recently updated their price target on PPBT (Purple Biotech)?
Which analyst has the current lower performing score on PPBT (Purple Biotech) with a proven track record?
Which analyst has the most public recommendations on PPBT (Purple Biotech)?
Which analyst is the currently most bullish on PPBT (Purple Biotech)?
Which analyst is the currently most reserved on PPBT (Purple Biotech)?
